Cargando…

Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening

OBJECTIVE: Analysis of interval cancers is critical in determining the sensitivity of screening and represents an objective measure of the quality of mammography screening program (MSP). METHODS: Period analyzed: from 2006 to 2012. The rate of screen-detected, interval cancers and program sensitivit...

Descripción completa

Detalles Bibliográficos
Autores principales: Steponaviciene, Laura, Vincerzevskiene, Ieva, Briediene, Ruta, Urbonas, Vincas, Vanseviciute-Petkeviciene, Rasa, Smailyte, Giedre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755864/
https://www.ncbi.nlm.nih.gov/pubmed/31502471
http://dx.doi.org/10.1177/1073274819874122
_version_ 1783453310517248000
author Steponaviciene, Laura
Vincerzevskiene, Ieva
Briediene, Ruta
Urbonas, Vincas
Vanseviciute-Petkeviciene, Rasa
Smailyte, Giedre
author_facet Steponaviciene, Laura
Vincerzevskiene, Ieva
Briediene, Ruta
Urbonas, Vincas
Vanseviciute-Petkeviciene, Rasa
Smailyte, Giedre
author_sort Steponaviciene, Laura
collection PubMed
description OBJECTIVE: Analysis of interval cancers is critical in determining the sensitivity of screening and represents an objective measure of the quality of mammography screening program (MSP). METHODS: Period analyzed: from 2006 to 2012. The rate of screen-detected, interval cancers and program sensitivity were measured. A comparison of screen-detected and interval cancers was performed. RESULTS: During the period of the study, 429 473 women were screened and 1297 were found to have cancer. The overall screen-detected cancer rate was 30.2 per 10 000 women screened. Four hundred thirty-one case of interval cancers have occurred during the period of the study. The interval cancer ratio (ICR) was 0.25. Overall sensitivity of MSP amounted to 75.1%. Slightly lower sensitivity was found among the youngest age-group, especially for those with lobular cancers. Interval cancers were bigger in size, more often with metastases in lymph nodes, than screen-detected cancers, but these differences were not statistically significant. CONCLUSIONS: Overall program sensitivity in Lithuania is about 75%, ICR is 0.25, and these parameters are comparable to other European countries.
format Online
Article
Text
id pubmed-6755864
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-67558642019-09-27 Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening Steponaviciene, Laura Vincerzevskiene, Ieva Briediene, Ruta Urbonas, Vincas Vanseviciute-Petkeviciene, Rasa Smailyte, Giedre Cancer Control Original Research Paper OBJECTIVE: Analysis of interval cancers is critical in determining the sensitivity of screening and represents an objective measure of the quality of mammography screening program (MSP). METHODS: Period analyzed: from 2006 to 2012. The rate of screen-detected, interval cancers and program sensitivity were measured. A comparison of screen-detected and interval cancers was performed. RESULTS: During the period of the study, 429 473 women were screened and 1297 were found to have cancer. The overall screen-detected cancer rate was 30.2 per 10 000 women screened. Four hundred thirty-one case of interval cancers have occurred during the period of the study. The interval cancer ratio (ICR) was 0.25. Overall sensitivity of MSP amounted to 75.1%. Slightly lower sensitivity was found among the youngest age-group, especially for those with lobular cancers. Interval cancers were bigger in size, more often with metastases in lymph nodes, than screen-detected cancers, but these differences were not statistically significant. CONCLUSIONS: Overall program sensitivity in Lithuania is about 75%, ICR is 0.25, and these parameters are comparable to other European countries. SAGE Publications 2019-09-10 /pmc/articles/PMC6755864/ /pubmed/31502471 http://dx.doi.org/10.1177/1073274819874122 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Paper
Steponaviciene, Laura
Vincerzevskiene, Ieva
Briediene, Ruta
Urbonas, Vincas
Vanseviciute-Petkeviciene, Rasa
Smailyte, Giedre
Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening
title Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening
title_full Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening
title_fullStr Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening
title_full_unstemmed Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening
title_short Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening
title_sort breast cancer screening program in lithuania: interval cancers and program sensitivity after 7 years of mammography screening
topic Original Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755864/
https://www.ncbi.nlm.nih.gov/pubmed/31502471
http://dx.doi.org/10.1177/1073274819874122
work_keys_str_mv AT steponavicienelaura breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening
AT vincerzevskieneieva breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening
AT briedieneruta breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening
AT urbonasvincas breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening
AT vanseviciutepetkevicienerasa breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening
AT smailytegiedre breastcancerscreeningprograminlithuaniaintervalcancersandprogramsensitivityafter7yearsofmammographyscreening